Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (31-40 of 392) with videos related to

Pageof 40
Sort By:
Expert Review of Anti-Infective Therapy|December 10, 2014
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseasesSeyedmojtaba Seyedmousavi, Paul E Verweij, Johan W Mouton
Antimicrobial Agents and Chemotherapy|June 20, 2007
Concentration-effect relationship of ceftazidime explains why the time above the MIC is 40 percent for a static effect in vivoJohan W Mouton, Nieko Punt, Alexander A Vinks
The Journal of Antimicrobial Chemotherapy|November 30, 2012
Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumoniaAnouk E Muller, Nieko Punt, Johan W Mouton
The Journal of Hospital Infection|May 19, 2001
Colonization and infection by Serratia species in a paediatric surgical intensive care unitM J Albers, J W Mouton, D Tibboel
Clinical Therapeutics|August 25, 2005
A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unitJohan W Mouton, Nieko Punt, Alexander A Vinks
Clinical and Experimental Dermatology|January 16, 2004
A new type of minocycline-induced cutaneous hyperpigmentationR W Mouton, H F Jordaan, J W Schneider
The Journal of Antimicrobial Chemotherapy|August 24, 2018
Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precisionJohan W Mouton, Joseph Meletiadis, Andreas Voss, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
<i>In Vitro</i> and <i>In Vivo</i> Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatusMaria Siopi, Johan W Mouton, Spyros Pournaras, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusionJ W Mouton, A A Vinks, N C Punt
Antimicrobial Agents and Chemotherapy|August 26, 2003
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratiosF Scaglione, J W Mouton, R Mattina, et al.
Pageof 40

Showing results (31-40 of 392) with videos related to

Sort By:
Pageof 40
Expert Review of Anti-Infective Therapy|December 10, 2014
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseasesSeyedmojtaba Seyedmousavi, Paul E Verweij, Johan W Mouton
Antimicrobial Agents and Chemotherapy|June 20, 2007
Concentration-effect relationship of ceftazidime explains why the time above the MIC is 40 percent for a static effect in vivoJohan W Mouton, Nieko Punt, Alexander A Vinks
The Journal of Antimicrobial Chemotherapy|November 30, 2012
Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumoniaAnouk E Muller, Nieko Punt, Johan W Mouton
The Journal of Hospital Infection|May 19, 2001
Colonization and infection by Serratia species in a paediatric surgical intensive care unitM J Albers, J W Mouton, D Tibboel
Clinical Therapeutics|August 25, 2005
A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unitJohan W Mouton, Nieko Punt, Alexander A Vinks
Clinical and Experimental Dermatology|January 16, 2004
A new type of minocycline-induced cutaneous hyperpigmentationR W Mouton, H F Jordaan, J W Schneider
The Journal of Antimicrobial Chemotherapy|August 24, 2018
Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precisionJohan W Mouton, Joseph Meletiadis, Andreas Voss, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
<i>In Vitro</i> and <i>In Vivo</i> Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatusMaria Siopi, Johan W Mouton, Spyros Pournaras, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusionJ W Mouton, A A Vinks, N C Punt
Antimicrobial Agents and Chemotherapy|August 26, 2003
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratiosF Scaglione, J W Mouton, R Mattina, et al.
Pageof 40